The HINT1 Knockout A-549 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population derived from the human A-549 lung adenocarcinoma cell line, designed for loss-of-function studies of the HINT1 gene. This product provides a heterogeneous pool of cells harboring targeted disruption of HINT1, enabling researchers to investigate the functional consequences of HINT1 ablation in a lung cancer model. The polyclonal format offers a robust population-level knockout that avoids clonal selection artifacts while maintaining genetic diversity suitable for pooled screening and bulk phenotypic analyses.
A-549 cells are a widely utilized model of human lung adenocarcinoma, originally isolated from a male patient with alveolar basal epithelial cell carcinoma. These cells exhibit characteristics of alveolar type II pneumocytes and carry an activating KRAS G12S mutation, which renders them dependent on oncogenic RAS signaling. The A-549 line is commonly employed in cancer biology to study tumor cell proliferation, apoptosis resistance, and drug response, making it a relevant host for assessing the tumor suppressor functions of HINT1.
HINT1 encodes a histidine triad nucleotide-binding protein that functions as a nucleotide phosphoramidase and acyl-AMP hydrolase, and additionally acts as a transcription co-regulator with tumor suppressor properties. Mechanistically, HINT1 integrates into the p53 and Wnt/??-catenin signaling axes. It is transcriptionally activated by p53 in response to DNA damage signals and, in turn, modulates downstream targets including Cyclin D1, c-Myc, and pro-apoptotic factors such as Bax and Apaf-1. HINT1 also interacts with transcription factors MITF and USF2, and forms complexes with PKC?? and Pontin, thereby influencing ??-catenin/TCF-mediated transcriptional programs. Disruption of HINT1 leads to elevated Wnt/??-catenin pathway activity and diminished p53-dependent apoptosis, potentially enhancing cell proliferation and survival.
In the A-549 lung adenocarcinoma background, which harbors an oncogenic KRAS G12S mutation, the HINT1 knockout model allows dissection of how this tumor suppressor interfaces with RAS-driven proliferation and p53-mediated apoptosis. The polyclonal cell population enables the study of heterogeneous responses to loss of HINT1, reflecting the genetic diversity within a tumor mass. Moreover, the model is valuable for investigating the interplay between HINT1 function and the Wnt/??-catenin pathway, as well as assessing how nucleotide phosphoramidase activity influences lung cancer cell behavior.
Researchers can employ these cells in a variety of functional assays to explore HINT1-related biology. For example, Western blotting and RT-qPCR can quantify changes in ??-catenin/TCF targets such as Cyclin D1 and c-Myc, while the TCF/LEF luciferase reporter assay directly measures Wnt pathway activity. Proliferation can be assessed via MTT and colony formation assays, and apoptosis induction monitored through Annexin V staining and analysis of Bax, Apaf-1, and caspase activation. These tools support investigations into tumor suppressor mechanisms, Wnt signaling pathway interrogation, and drug sensitivity profiling in lung adenocarcinoma. For further details or to discuss how this model can be integrated into your research, please contact Ascent Research.
